Related Articles
Lamivudine-resistant rtL180M and rtM204I/V are persistently dominant during combination rescue therapy with entecavir and adefovir for hepatitis B
Evolution of entecavir-resistant hepatitis B virus during entecavir and adefovir dipivoxil combination therapy
Evaluation of the dynamic pattern of viral evolution in patients with virological breakthrough during treatment with nucleoside/nucleotide analogs by ultra‑deep pyrosequencing
Brca1 is involved in tolerance to adefovir dipivoxil‑induced DNA damage
Association between clinical features and YMDD mutations in patients with chronic hepatitis B following lamivudine therapy